Comparez les meilleurs médecins Thrombocytopénie et les prix en Israël. Trouvez votre meilleure correspondance ici.
Nous sélectionnons à la main les meilleurs médecins selon vos besoins et votre budget.
Examiné médicalement par Fahad Mawlood
Éditeur Médical et Scientifique des DonnéesMeilleurs médecins
13
Israël
Avis
14000+
De vrais patients
Obtenez gratuitement des plans de traitement personnalisés et choisissez la meilleure option. Sans engagement · Aucun paiement pour nos services
Montrer d'abord :
Coût de la consultation disponible sur demande.
Le Dr El Hasid a réalisé plus de 300 transplantations de moelle osseuse et de sang de cordon ombilical à l'hôpital pour enfants Dana Dwek. Elle y dirige le service d'onco-hématologie et d'oncologie pédiatrique.
Le Dr Ram a pratiqué plusieurs centaines de greffes de cellules souches pour des troubles sanguins tels que la thrombocytopénie au centre médical Sourasky (Ichilov). Il possède une triple certification en médecine interne, en hématologie et en oncologie médicale.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Spécialisation en transplantation de moelle osseuse – Le Dr Shapira apporte une vaste expertise dans la gestion des cas de thrombocytopénie.
Le Dr Fredi Aviv possède 31 ans d'expérience en onco-hématologie au centre médical Sourasky.
Le Dr Dror Levin dirige le département d'hémato-oncologie pédiatrique du centre médical Sourasky, se spécialisant dans les troubles sanguins chez l'enfant.
Le Dr Kirshner contribue activement à l'avancement de l'hématologie par le biais d'essais cliniques, notamment un essai de phase III pour le cancer de la prostate résistant à la castration.
Le Dr Gal Goldstein est un spécialiste en hémato-oncologie pédiatrique au centre médical Hadassah, classé par Forbes comme l'un des meilleurs médecins d'Israël.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Choisir une clinique à l'étranger peut être stressant. Chez Bookimed, avec plus de 800 000 patients aidés, nous comprenons vos préoccupations. Nous savons comment trouver des médecins de confiance, les meilleures options qualité-prix, et des solutions pour les cas les plus complexes. Nous sommes là pour vous guider à chaque étape.
Yan Matsiivskiy
Responsable de l'équipe de coordination médicale
4300++ parcours patients accompagnés
3 années chez Bookimed
142 patients du Israel ont trouvé leur médecin grâce à nous ce mois-ci
Quiz de 2 minutes
Indiquez-nous votre objectif, budget, délai
Appariement humain + IA
Notre algorithme trouve des correspondances, le coordinateur vérifie l'adéquation
Vos options prêtes
Comparez les prix, forfaits, dates. Discutez avec votre coordinateur
Trop de choix ?
Accompagnement de votre traitement
Coordinateurs médicaux personnels formés
| Classement | Médecin | expérience | Bon choix pour | Ce qui les distingue | Clinique et emplacement | Consultation |
|---|---|---|---|---|---|---|
| #1 | 24 années d'expérience | Sur demande | Sur demande | Israël | Prix sur demande | |
| #2 | 38 années d'expérience | Greffes de moelle osseuse pédiatriques | Chef de l'onco-hématologie pédiatrique dans un grand hôpital pour enfants. Plus de 300 transplantations pédiatriques réalisées. Auteur publié et membre des principales sociétés d'hématologie américaines et israéliennes. | Israël | Prix sur demande | |
| #3 | 24 années d'expérience | Greffe de cellules souches pour la thrombocytopénie | A réalisé plusieurs centaines de transplantations de cellules souches, un traitement clé pour les cas graves. Titulaire d'une triple certification et auteur de plus de 30 articles scientifiques dans ce domaine. | Israël | Prix sur demande | |
| #4 | 36 années d'expérience | Greffe de moelle osseuse | Expertise en transplantation de moelle osseuse avec une expérience de haut niveau à Hadassah. Spécialisation en médecine interne avec un accent sur les pathologies hématologiques. | Israël | Prix sur demande | |
| #5 | 34 années d'expérience | Troubles sanguins complexes | Spécialiste en onco-hématologie avec des décennies d'expérience dans un centre médical de premier plan. Se concentre sur des plans de traitement personnalisés pour les patients atteints de troubles sanguins. | Israël | Prix sur demande | |
| #6 | 41 années d'expérience | Troubles sanguins pédiatriques | Dirige un service de premier plan en hématologie et oncologie pédiatrique en Israël. Spécialisé dans les troubles de la coagulation sanguine et les sarcomes chez les enfants. Formé dans les plus grands centres internationaux. | Israël | Prix sur demande | |
| #7 | 32 années d'expérience | Recherche hématologique avancée | Dirige des essais cliniques de pointe en hématologie, incluant une étude importante de phase III sur le cancer de la prostate. Double formation spécialisée en hématologie et en oncologie. | Israël | Prix sur demande | |
| #8 | 27 années d'expérience | Cas d'hémato-oncologie pédiatrique | Spécialiste reconnu par Forbes, à la tête du service d'oncologie pédiatrique d'Hadassah. Expertise en rétinoblastome et en médecine de précision avec transplantations haplo-identiques. | Israël | Prix sur demande |
Top Israeli hospitals for thrombocytopenia include Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These JCI-accredited institutions utilize advanced diagnostics and treatments like therapeutic apheresis and bone marrow transplantation. Specialist hematologists provide personalized protocols for both adult and pediatric immune thrombocytopenia cases.
Bookimed Expert Insight: Data reveals that Sheba Medical Center is a powerhouse for complex cases, with doctors like Dr. Avichai Shimoni and Dr. Abraham Avigdor bringing 30+ years of experience each. While many clinics offer standard care, Sheba’s leadership in CAR-T and mitochondrial therapies provides a safety net for patients who do not respond to traditional thrombocytopenia treatments.
Patient Consensus: Patients emphasize finding a hematologist who prioritizes long-term outpatient management over immediate invasive surgery. Many note that home monitoring and modern drug therapies can often replace frequent hospital stays for stable platelet counts.
Israeli clinics provide advanced hematology and oncology treatments, including targeted therapies and CAR T-cell technology. Specialist centers like Sourasky Medical Center (Ichilov) and Hadassah offer personalized protocols for blood disorders, pediatric oncology, and complex surgeries. These facilities utilize high-precision diagnostics and robotic systems to ensure high success rates.
Bookimed Expert Insight: Israeli hematology programs distinguish themselves through high-volume expertise and research integration. For instance, Dr. Ron Ram at Sourasky Medical Center has performed several hundred stem cell transplants. This concentration of clinical experience at accredited facilities like Sheba or Hadassah often leads to 90% success rates in complex oncology treatments. Many top doctors also hold prestigious rankings from Forbes, signaling consistent peer-reviewed excellence.
Patient Consensus: Patients value the quick effectiveness of treatments like corticosteroids and IVIg for acute cases. They often note the importance of discussing steroid-sparing options early to manage potential long-term side effects.
Leading thrombocytopenia specialists in Israel include Dr. Ron Ram at Sourasky Medical Center and Prof. Avichai Shimoni at Sheba Medical Center. They specialize in adult hematology and stem cell transplantation. For pediatric cases, Dr. Dror Levin and Dr. Gal Goldstein provide expert care.
Bookimed Expert Insight: While many seek out large state facilities like Sheba or Hadassah, data shows Sourasky Medical Center maintains a 90% oncology success rate with a high concentration of specialized hematologists. For patients needing faster access, private clinics in Tel Aviv or Herzliya often offer consultations with these same top-tier hospital heads within days rather than weeks.
Patient Consensus: Patients note that Israeli specialists often explore advanced drug therapies or lifestyle adjustments before recommending surgery. While medical care is highly rated, many suggest using private clinics to avoid the 4–6 week wait times common at large academic centers.
Israel offers specialized pediatric thrombocytopenia care through dedicated hemato-oncology departments. Centers like Hadassah and Sourasky prioritize multidisciplinary management for immune thrombocytopenia and rare platelet disorders. Board-certified hematologists oversee diagnostic immunograms and personalized treatment protocols. These experts often collaborate with international research networks to ensure advanced care standards.
Bookimed Expert Insight: Israeli pediatric centers stand out because their department heads, like Dr. Gal Goldstein and Prof. Amos Toren, often hold dual credentials in research and clinical care. This translates to faster access to novel protocols for refractory cases. While US programs are often standalone, Israel integrates these specialized treatments into massive tertiary hubs like Sheba or Sourasky, ensuring 24/7 access to full-scale emergency and surgical facilities if bleeding occurs.
Patient Consensus: Patients note that care is highly personalized under specific hematologists. They suggest asking for a formal coordinator to help manage school notifications and bleeding precaution education during treatment.
International patients typically stay in Israel for 7 to 21 days for thrombocytopenia care. This timeframe allows for diagnostics like immunograms and initial treatments such as plasmapheresis or plasma exchange. Hematologists require patients to reach stable platelet counts before authorizing air travel to ensure safety.
Bookimed Expert Insight: Israeli hematology centers like Sourasky or Sheba often use integrated EHRs to sync laboratory results with international patients' hometown doctors. This digital infrastructure allows specialists like Dr. Ron Ram to monitor recovery remotely. Patients should prioritize clinics with advanced telemedicine capabilities to simplify post-treatment transitions and reduce repeat travel.
Patient Consensus: Patients note it is vital to buffer an extra week in Israel for potential travel disruptions. They emphasize confirming that platelet monitoring kits can be shipped home before leaving the clinic.